Allelic deletions in renal tumors: histopathological correlations - PubMed (original) (raw)
. 1993 Dec 1;53(23):5780-3.
Affiliations
- PMID: 8242636
Allelic deletions in renal tumors: histopathological correlations
J C Presti Jr et al. Cancer Res. 1993.
Abstract
Allelic loss on the short arm of chromosome 3 (3p) is considered to be one of the early detectable events in the pathogenesis of renal cell carcinoma (RCC). Conflicting reports, however, suggest that this event may be absent in some renal tumors. The present study attempts to further define subgroups of renal tumors associated with 3p deletions. In addition, we have also attempted to identify late genetic events associated with tumorigenesis and tumor progression. Eighty-two primary renal tumors (69 RCC and 13 oncocytic tumors) were analyzed by restriction fragment length polymorphism analysis directed at chromosomes 3, 11p, 17p, and 18q. Results were correlated with histopathological information. Deletions of 3p were seen in nonpapillary RCC of all cell types, but were absent in oncocytic and most papillary tumors. Among the 60 nonpapillary RCC, significant correlations were seen between deletion of 17p and tumor grade (P = 0.037), P stage (P = 0.027), and nodal metastases (P = 0.042). We therefore conclude that 3p deletions, although not specific to any cell type or histological pattern of RCC, are seen in a majority of clear cell nonpapillary RCC but are absent in oncocytic and most papillary tumors. Additional allelic losses on chromosome 17p are associated with advanced disease and, therefore, may be related to tumor progression. Further studies on larger series of patients with extended follow-up will be necessary to investigate the prognostic value of molecular genetic markers in RCC.
Similar articles
- Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC. Presti JC Jr, et al. Cancer Res. 1991 Mar 1;51(5):1544-52. Cancer Res. 1991. PMID: 1671759 - Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O. Ogawa O, et al. Cancer Res. 1992 Apr 1;52(7):1881-5. Cancer Res. 1992. PMID: 1348014 - Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O. Ogawa O, et al. Cancer Res. 1991 Feb 1;51(3):949-53. Cancer Res. 1991. PMID: 1671000 - Precancerous lesions in the kidney.
Van Poppel H, Nilsson S, Algaba F, Bergerheim U, Dal Cin P, Fleming S, Hellsten S, Kirkali Z, Klotz L, Lindblad P, Ljungberg B, Mulders P, Roskams T, Ross RK, Walker C, Wersäll P. Van Poppel H, et al. Scand J Urol Nephrol Suppl. 2000;(205):136-65. Scand J Urol Nephrol Suppl. 2000. PMID: 11144893 Review. - Evolving classification of renal cell neoplasia.
Delahunt B, Velickovic M, Grebe SK. Delahunt B, et al. Expert Rev Anticancer Ther. 2001 Dec;1(4):576-84. doi: 10.1586/14737140.1.4.576. Expert Rev Anticancer Ther. 2001. PMID: 12113090 Review.
Cited by
- Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al. Herman JG, et al. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4. doi: 10.1073/pnas.91.21.9700. Proc Natl Acad Sci U S A. 1994. PMID: 7937876 Free PMC article. - Origin of renal cell carcinomas.
Valladares Ayerbes M, Aparicio Gallego G, Díaz Prado S, Jiménez Fonseca P, García Campelo R, Antón Aparicio LM. Valladares Ayerbes M, et al. Clin Transl Oncol. 2008 Nov;10(11):697-712. doi: 10.1007/s12094-008-0276-8. Clin Transl Oncol. 2008. PMID: 19015066 Review. - Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
Eichenauer T, Shadanpour N, Kluth M, Göbel C, Weidemann S, Fraune C, Büscheck F, Hube-Magg C, Möller-Koop C, Dahlem R, Fisch M, Rink M, Riechardt S, Burandt E, Bernreuther C, Minner S, Simon R, Sauter G, Wilczak W, Clauditz T. Eichenauer T, et al. World J Surg Oncol. 2020 Jun 13;18(1):128. doi: 10.1186/s12957-020-01902-y. World J Surg Oncol. 2020. PMID: 32534597 Free PMC article. - A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression.
Zhang Z, Wondergem B, Dykema K. Zhang Z, et al. Adv Bioinformatics. 2010;2010:428325. doi: 10.1155/2010/428325. Epub 2010 Jul 5. Adv Bioinformatics. 2010. PMID: 20671976 Free PMC article. - Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.
Sanders ME, Mick R, Tomaszewski JE, Barr FG. Sanders ME, et al. Am J Pathol. 2002 Sep;161(3):997-1005. doi: 10.1016/S0002-9440(10)64260-5. Am J Pathol. 2002. PMID: 12213728 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical